What is included in my trial?
During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.
Standard Digital includes access to a wealth of global news, analysis and expert opinion. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. For a full comparison of Standard and Premium Digital, click here.
Change the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section.
What happens at the end of my trial?
If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for 65 € per month.
For cost savings, you can change your plan at any time online in the “Settings & Account” section. If you’d like to retain your premium access and save 20%, you can opt to pay annually at the end of the trial.
You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Compare Standard and Premium Digital here.
Any changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel.
Zxynwin on October 31st, 2023 at 19:27 UTC »
FUCK YEAH
Now hopefully it continues to decline! Dementia is one of my greatest fears.
etds3 on October 31st, 2023 at 18:32 UTC »
From another article that I didn’t have to pay for: “However, there is growing evidence that age-adjusted dementia prevalence has been declining in developed countries, possibly because of rising levels of education, a reduction in smoking, and better treatment of key cardiovascular risk factors such as high blood pressure.”
https://www.rand.org/news/press/2022/11/07.html
Hot_Flan1220 on October 31st, 2023 at 18:22 UTC »
Article is pay-to-play, but I'd put money on the unleading of petrol in the 1970s and 1980s.
As time passes, a person's cumulative exposure to this known toxin drops, reducing the associated affects that can include:
reduced cognitive development,
reduced intellectual performance,
heart disease and strokes,
and neurodegenerative diseases.